The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

What is Neuromodulation?

Breaking News Share

Company Plans Initial Public Offering

May 21, 2018 - ElectroCore filed Monday for a $75 million initial public offering on the Nasdaq, planning to trade under the symbol ECOR. Pricing details were not disclosed. (Nasdaq)

Neuromodulation Discussed at Urology Meeting

May 21, 2018 - A number of presentations at the annual meeting of the American Urological Association concerned neuromodulation. A presenter who discussed third-line therapies for overactive bladder said she considers percutaneous tibial nerve stimulation (PTNS) between second- and third-line treatment, or "level 2.5". She said it is easy to use, minimally invasive, has minimal adverse events, and has level 1 evidence. Meanwhile, she added that advantages of sacral nerve stimulation as a third-line therapy include its efficacy in also treating urinary retention and fecal incontinence.

Another presenter discussed an observational pilot study of 11 patients with sacral nerve stimulators for urinary urge incontinence who did not have their devices explanted before receiving 1.5T MRIs of the lumbar or pelvic area. The authors noted no more than minimal discomfort, and no change in therapeutic efficacy.

Finally, data were presented from 116 drug-naive patients who underwent 12 sessions with a percutaneous tibial neuromodulation system for overactive bladder. The RESET study was a multi-center, single arm, prospective study. (

Hospital in India Focuses on Chronic Pain Management

May 21, 2018 - A press release announces the availability of neuromodulation and other interventional pain procedures at a 50-bed hospital dedicated to the management of chronic pain in Calcutta, India. The announcement says the facility also provides training for specialists and pain management fellowships. (

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM